Determination of gabapentin in plasma by liquid chromatography with fluorescence detection after solid-phase extraction with a C18 column

Clinical Chemistry

Volumn 48, Issue 12, 2002, Pages 2259-2261

  Gauthier, Donna ^a   Gupta, Ram ^a  

^a ST JOSEPH S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN;

ARTICLE; CATION EXCHANGE; CONTROLLED STUDY; DERIVATIZATION; DRUG BLOOD LEVEL; DRUG DETERMINATION; EPILEPSY; FLUORESCENCE; FLUOROMETRY; HEMOLYSIS; HUMAN; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; SOLID PHASE EXTRACTION; SPECTROPHOTOMETRY;

EID: 0036892181     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/48.12.2259     Document Type: Article

References (16)

1. Tomson T, Johannessen Sl. Therapeutic monitoring of the new antiepileptic drugs. Eur J Clin Pharmacol 2000;55:697-705.
2. Patsalos PN. New antiepileptic drugs. Ann Clin Biochem 1999;36:10-9.
3. Ifa DR, Falci M, Moraes ME, Bezerra FA, Moraes MO, deNucci G. Gabapentin quantification in human plasma by high performance liquid chromatography coupled to electrospray tandem mass spectrometry. Application to bioequivalence study. J Mass Spectrom 2001;36:188-94.
4. Lensmeyer GL, Kempf T, Gidal BE, Wiebe DA. Optimized method for determination of gabapentin in serum by high-performance liquid chromatography: Ther Drug Monit 1995;17;251-8.
5. Fraser A, MacNeil W. HPLC analysis of gabapentin: a new anticonvulsant drug. In: Sunshine I, ed. Recent Developments in Therapeutic Drug Monitoring and Clinical Toxicology. New York: Marcel Dekker, 1992:313-20.
6. Garcia LL, Shihabi ZK, Oles K. Determination of gabapentin in serum by capillary electrophoresis. J Chromatogr B 1995;669:157-62.
7. Chollet DF, Goumaz L, Juliano C, Anderegg G. Fast isocratic high performance liquid chromatographic assay method for the simultaneous determination of gabapentin and vigabatrin in human serum. J Chromatogr B 2000;746:311-4.
8. Tang PH, Miles MV, Glauser TA, DeGrauw T. Automated microanalysis of gabapentin in human serum by high performance liquid chromatography with fluorometric detection. J Chromatogr B 1999;727:125-9.
9. Jiang Q, Li S. Rapid high-performance liquid chromatographic determination of serum gabapentin. J Chromatogr B 1999;727:119-23.
10. Ratnaraj N, Patsalos PN. A high performance liquid chromatography micro-method for the simultaneous determination of vigabatrin and gabapentin in serum. Ther Drug Monit 1998;20 430-4.
11. Wad N, Kramer G. Sensitive high-performance liquid chromatographic method with fluorometric detection for the simultaneous determination of gabapentin and vigabatrin in serum and urine. J Chromatogr B 1998;705: 154-8.
12. Forrest G, Sills GJ, Leach JP, Brodie MJ. Determination of gabapentin in plasma by high-performance liquid chromatography. J Chromatogr B 1996; 681:421-5.
13. Van Lente F, Gatautis V. Cost-efficient use of gas chromatography-mass spectrometry: A "piggyback" method for analysis of gabapentin. Clin Chem 1998;44:2044-5.
14. Wolf CE, Saady JJ, Poklis A. Determination of gabapentin in serum using solid phase extraction and gas-liquid chromatography. J Anal Toxicol 1996; 20:498-501.
15. Kushnir MM, Crossett J, Brown PI, Urry FM. Analysis of gabapentin in serum and plasma by solid-phase extraction and gas chromatography mass spectrometry for therapeutic drug monitoring. J Anal Toxicol 1999;23:1-6.
16. Gupta R, Maelly L. Liquid chromatographic determination of mexiletine and tocainide in human plasma with fluorescence detection after reaction with a modified o-phthalaldehyde reagent. J Chromatogr 1985;344:221-30.